# ERN GUARD-Heart

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/ern-guard-heart/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 73 |
| Citations | 136,676 |
| City | Amsterdam |
| Country | NL |
| Description | ERN GUARD-Heart is a research organisation in Amsterdam, NL. OpenAlex records 1,716 works and 136,676 citations for it. 958 researchers list it as their most recent affiliation. |
| Homepage | https://guardheart.ern-net.eu/ |
| OpenAlex ID | https://openalex.org/I4210142685 |
| Region | North Holland |
| Researchers | 958 |
| ROR ID | https://ror.org/055s7a943 |
| Type | healthcare |
| Works | 1,716 |

## University papers

- [Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases](https://scholariq.org/papers/current-state-of-knowledge-on-aetiology-diagnosis-management-and-therapy-of/)
- [Cholangiocarcinoma 2020: the next horizon in mechanisms and management](https://scholariq.org/papers/cholangiocarcinoma-2020-the-next-horizon-in-mechanisms-and-management/)
- [Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/mavacamten-for-treatment-of-symptomatic-obstructive-hypertrophic-cardiomyopathy/)
- [A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis](https://scholariq.org/papers/a-placebo-controlled-trial-of-obeticholic-acid-in-primary-biliary-cholangitis/)
- [Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis](https://scholariq.org/papers/patient-age-sex-and-inflammatory-bowel-disease-phenotype-associate-with-course/)
- [Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆](https://scholariq.org/papers/genome-wide-association-study-of-non-alcoholic-fatty-liver-and-steatohepatitis/)
- [Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis](https://scholariq.org/papers/genome-wide-meta-analyses-identify-three-loci-associated-with-primary-biliary/)
- [Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis](https://scholariq.org/papers/comparison-of-the-clinical-features-and-clinical-course-of-antimitochondrial/)
- [An Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease](https://scholariq.org/papers/an-expert-consensus-document-on-the-management-of-cardiovascular-manifestations/)
- [Understanding short bowel syndrome: Current status and future perspectives](https://scholariq.org/papers/understanding-short-bowel-syndrome-current-status-and-future-perspectives/)
- [Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the <i>TTN</i> Gene](https://scholariq.org/papers/clinical-phenotypes-and-prognosis-of-dilated-cardiomyopathy-caused-by-truncating/)
- [Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score](https://scholariq.org/papers/pretreatment-prediction-of-response-to-ursodeoxycholic-acid-in-primary-biliary/)

## University top topics

Showing 8 of 25.

- [Cardiac electrophysiology and arrhythmias](https://scholariq.org/topics/cardiac-electrophysiology-and-arrhythmias/)
- [Cardiomyopathy and Myosin Studies](https://scholariq.org/topics/cardiomyopathy-and-myosin-studies/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)
- [Cardiovascular Effects of Exercise](https://scholariq.org/topics/cardiovascular-effects-of-exercise/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.